| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $194.8B | $163.1B | $154.0B | $144.5B | $126.0B | $111.1B | $18.9B | $16.6B |
| Cost of Revenue | $2.7B | $2.7B | $3.6B | $7.0B | $4.9B | $3.3B | $2.5B | $2.4B |
| Gross Profit | $14.2B | $17.1B | $17.6B | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $12.9B | $12.4B | $12.6B | $11.6B | $10.2B | $9.9B | $6.5B | $6.0B |
| Operating Income | $-7.6B | $3.2B | $2.9B | $1.3B | $1.8B | $3.1B | $1.8B | $1.5B |
| Net Income | $-6.7B | $3.3B | $2.7B | $1.2B | $1.3B | $1.8B | $0.2B | $0.2B |
| EPS (Basic) | $-13.53 | $6.33 | $4.97 | $2.09 | $2.31 | $3.17 | $0.50 | $0.59 |
| EPS (Diluted) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 | $3.12 | $0.49 | $0.57 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $76.7B | $82.4B | $84.6B | $76.9B | $78.4B | $68.7B | $41.0B | $30.9B |
| Current Assets | $40.4B | $38.0B | $40.8B | $30.1B | $28.5B | $23.4B | $20.3B | $12.0B |
| Cash & Equivalents | $17.9B | $14.1B | $17.2B | $12.1B | $13.1B | $10.8B | $12.1B | $5.3B |
| Total Liabilities | $56.7B | $55.9B | $58.7B | $52.6B | $51.4B | $42.8B | $28.3B | $19.9B |
| Current Liabilities | $36.7B | $34.3B | $36.7B | $28.5B | $25.8B | $21.6B | $12.9B | $12.0B |
| Stockholders' Equity | $20.0B | $26.4B | $25.8B | $24.1B | $26.8B | $25.8B | $12.6B | $10.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.1B | $0.2B | $8.1B | $6.3B | $4.2B | $5.5B | $1.5B | $1.2B |
| Investing Cash Flow | $0.5B | $-1.1B | $-1.2B | $-2.9B | $-3.3B | $-7.0B | $-1.5B | $-4.6B |
| Capital Expenditures | $0.8B | $0.6B | $0.8B | $1.0B | $0.9B | $0.9B | $0.7B | $0.7B |
| Financing Cash Flow | $-1.6B | $-2.4B | $-1.7B | $-4.2B | $1.4B | $0.3B | $6.8B | $4.6B |